A systematic overview of published antimalarial drug trials

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 2, 2004, Pages 73-81

  Myint, Hla Yin ^a   Tipmanee, Prakaykaew ^a   Nosten, François ^a,b,c   Day, Nicholas P J ^a,c   Pukrittayakamee, Sasithon ^a   Looareesuwan, Sornchai ^a   White, Nicholas J ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Antimalarial drug trials; Review

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEETHER; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLORPROGUANIL; CHLORPROGUANIL PLUS DAPSONE; CLINDAMYCIN; CYCLOGUANIL; DIHYDROARTEMISININ; DOXYCYCLINE; FANSIDAR; FANSIMEF; HALOFANTRINE; MALOPRIM; MEFLOQUINE; METAKELFIN; PIPERAQUINE; PRIMAQUINE; PYRIMETHAMINE; PYRONARIDINE; QUINIDINE; QUININE; TETRACYCLINE;

ADULT; AFRICA; ASIA; CHILD; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PREGNANCY; REVIEW; SIDE EFFECT; STATISTICAL ANALYSIS; THAILAND; TREATMENT FAILURE;

PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX;

EID: 1642513782     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)00014-2     Document Type: Review

References (19)

1. Bruce-Chwatt, L.J., 1988. History of malaria from prehistory to eradication, in Wernsdorfer, W.H., McGregor, I. (Eds.), Malaria: Principles and Practice of Malariology. Churchill Livingstone, Edinburgh, pp. 1-59.
2. Covell, G., 1967. Chemotherapy of malaria. WHO Monograph Series, 27.
3. Ding, G.S., 1988. Recent studies on antimalarials in China: a review of literature since 1980. Int. J. Exp. Clin. Chemother. 1, 9-22.
4. Harinasuta, T, Bunnag, D., Wernsdorfer, W.H., 1983. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bull. World Health Organ 61, 299-305.
5. Hatton, C.S., Peto, TE., Bunch, C., Pasvol, G., Russell, S.J., Singer, C.R., Edwards, G., Winstanley, P., 1986. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1, 411-414.
6. Kissinger, E., Hien, T.T., Hung, N.T., Nam, N.D., Tuyen, N.L., Dinh, B.V., Mann, C., Phu, N.H., Loc, P.P., Simpson, J.A., White, N.J., Farrar, J.J., 2000. Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. Am. J. Trop. Med. Hyg. 63, 48-55.
7. Mayxay, M., Chotivanich, K., Pukrittayakamee, S., Newton, P., Looareesuwan, S., White, N.J., 2001. Contribution of humoral immunity to the therapeutic response in falciparum malaria. Am. J. Trop. Med. Hyg. 65, 918-923.
8. Miller, K.D., Lobel, H.O., Satriale, R.F., Kuritsky, J.N., Stern, R., Campbell, C.C., 1986. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am. J. Trop. Med. Hyg. 35, 451-458.
9. Nosten, F., Luxemburger, C., ter Kuile, F.O., Woodrow, C., Pa Eh, J., Chongsuphajaisiddhi, T., White, N.J., 1994. Treatment of multi-drug resistant Plasmodium folciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 170, 971-977.
10. van Vugt, M., Angus, B.M., Price, R.N., Mann, C., Simpson, J.A., Poletto, C., Eh Htoo, Looareesuwan, S., White, N.J., Nosten, F, 2000. A case-control auditory evaluation of patients treated with artemisinin derivatives for multi-drug resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 62, 65-69.
11. van Vugt, M., Ezzet, F., Nosten, F., White, N.J., 1999. No evidence of cardiotoxicity during antimatarial treatment with artemether-lumefantrine. Am. J. Trop. Med. Hyg. 61, 964-967.
12. White, N.J., 2002. The assessment of antimalarial drug efficacy. Trends Parasitol. 18, 458-464.
13. White, N.J., 2003. Malaria, in Cook, G.C., Zumla, A. (Eds.), Manson's Tropical Diseases. 21st ed. W.B. Saunders, London, pp. 1205-1296.
14. WHO, 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Group. World Health Organization Technical Report Series 529, 30-35.
15. WHO; 1990. Practical chemotherapy of malaria. World Health Organization Technical Report Series, 805.
16. WHO, 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96. 1077.
17. WHO Roll Back Malaria Technical Consultation, 2001. Antimalarial drug combination therapy. WHO/CDS/RBM/2001. 35.
18. York, W., Macfie, J.W.S., 1924. Observations on malaria made during treatment of general paralysis. Trans. R. Soc. Trop. Med. Hyg. 12-44.
19. Zitelli, B.J., Alexander, J., Taylor, S., Miller, K.D., Howrie, D.L., Kuritsky, J.N., Perez, T.H., Van Thiel, D.H., 1987. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar). Ann. Intern. Med. 106, 393-395.